Dr Samar Al Muntaser Background There is a paucity of literature - - PowerPoint PPT Presentation

dr samar al muntaser background
SMART_READER_LITE
LIVE PREVIEW

Dr Samar Al Muntaser Background There is a paucity of literature - - PowerPoint PPT Presentation

Dr Samar Al Muntaser Background There is a paucity of literature on the epidemiology, clinical characteristics and investigation tools for the pediatric age group with acquired demyelination syndromes. Any disease that causes


slide-1
SLIDE 1

Dr Samar Al Muntaser

slide-2
SLIDE 2

Background

  • There is a paucity of literature on the epidemiology, clinical characteristics

and investigation tools for the pediatric age group with acquired demyelination syndromes.

  • Any disease that causes damage to the myelin sheath that slows or stops

nerve signals is called a demyelinating disease. There are numbers of demyelinating diseases in childhood. Causes are multifactorial and include genetic, post infectious, post-immunization, and autoimmune (the body produces proteins, which damage its own tissue).

  • No cure exists for demyelinating diseases; early recognition, supportive care

and early treatment with medications may help minimize and manage

  • symptoms. Rehabilitation therapies are of particular importance.
slide-3
SLIDE 3

Audit Objectives:

  • To determine the early symptoms of demyelinating

syndromes.

  • To identify the types of demyelination
  • To assess the clinical investigation, MRI features of

childhood demyelinating syndromes.

  • To evaluate the treatment modalities.
slide-4
SLIDE 4

Methods:

  • It is a retrospective study done on all pediatric patients

admitted with demyelinating syndromes from January 2010 until Jan 2019.

  • Data was collected from the patients records after

approvals.

  • Patients were assessed regarding clinical presentation,

investigation and management plans on regular basis.

slide-5
SLIDE 5

Results:

  • Total numbers of patients diagnosed as demeylination

syndrome: 13 patients.

  • Their age range at presentations : 29 months to 11 6/12

years.

  • 8 Patients were female and 5 males
  • All patients had normal birth history , normal development

and family history.

slide-6
SLIDE 6
  • Triggering factors: 8 cases presented with history of fever
  • r viral infection
slide-7
SLIDE 7

Clinical presentations :

NECK PAIN / STIFFENESS DROWSY HEADACHE MOTOR TICS IRRITABLE NIL 4 (30.7%) 3 (23%) 2 (15%) 1 (7.7%) 1 (7.7%) 1 (7.7%)

slide-8
SLIDE 8

CNS examination:

  • Cranial nerves:

1 patient with squint and diplopia (7.6%) 1 patient with left facial weakness (7.6%)

  • Power:

6 patients with weakness (46%)

  • Tone:

1 was hypertonic (7.6%), 1was hypotonic (7.6%) and 84.6% were normal

  • Reflexes:

9 patients had brisk reflexes ( 69%), 7.6% hyporeflexia and 7.6% absent reflex

  • Gait
  • 7 patients had unsteady gait (53.8)
slide-9
SLIDE 9

Investigations :

  • CSF: 1 patient with positive HSV1

3 with high protein

  • OCB/CSF:

3 were positive 3 were not done 7 were negative

  • AQ4:

5 negative 8 not done

slide-10
SLIDE 10

Investiagtions :

  • EEG:

4 patients had focal slowing (30.7%) 1 epileptiform discharges (7.6%) 1 not done ( 7.6%) 7 were normal (53.8%)

  • MRI:

7 patients with signs of ADEMS (53.8%) 6 patients with signs of transverse myelitis (46%)

slide-11
SLIDE 11

Diagnosis:

slide-12
SLIDE 12

Management

slide-13
SLIDE 13

Conclusions

  • Though demyelinating syndromes is rare in children , yet

it seems to be under diagnosed due to paucity of investigations tools.

  • Re-audit of new patients prospectively

with possible demyelination to implement

  • ther

investigations tools not used previously, to standardize treatment care.